Orabi, K. “Microbial Metabolism of Rofecoxib, A Selective COX-2 Inhibitor”. International Journal of Biotechnology for Wellness Industries, vol. 1, no. 4, Jan. 2013, pp. 235-40, doi:10.6000/1927-3037.2012.01.04.3.